Bulk Active : Alendronate Sodium
Pharmacologic Activity :
Anti-Osteoporosis
CAS No : 121268-17-5
Specifications : BP/EP/USP
Regulatory compliance : eDMF(CTD)
TEST | USP 36 | BP 2013/EP 7.4 |
CHARACTERS | White, free-flowing powder. | A white or almost white, crystalline powder, |
SOLUBILITY | Soluble in water, very slightly soluble in dimethyl sulfoxide, in methyl alcohol, and in propylene glycol; practically insoluble in acetone, in acetonitrile, in alcohol, in chloroform, and in isopropyl alcohol. | soluble in water, very slightly soluble in methanol, practically insoluble in methylene chloride |
IDENTIFICATION INFRARED ABSORPTION
Test for sodium |
Infrared absorption spectrum of sample should be concordant with the reference spectrum of Alendronate Sodium Trihydrate It should respond to the test for Sodium. | Infrared absorption spectrum of sample should be concordant with the reference spectrum of Sodium Alendronate working reference standard.
It should respond to the test for Sodium |
Appearance of solution | ----- | Solution S is clear and not more intensely coloured than reference solution B7 or BY7. |
pH of Solution S | ----- | Between 4.0 to 5.0 |
4-Aminobutanoic acid by TLC | ----- | Any spots corresponding to 4-aminobutanoic acid in the chromatogram obtained with the test solution are not more intense than the spot in the chromatogram obtained with reference solution (b) (0.5 per cent). |
Phosphate
Phosphite Individual Impurity Total mpurity |
------
------ NMT 0.1% NMT 0.5% |
NMT 0.5% NMT 0.5% ------ ------ |
LOSS ON DRYING | Between 16.1% to 17.1% W/W | Between 16.1% to 17.1% W/W |
HEAVY METALS | Not more than 0.001% | NMT 10 ppm |
ASSAY | Between 98.0% and 102.0% w/w | Between 98.0% and 102.0% w/w |